Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers.(JCOG0206, OVCA-NAC-P2)
Phase 2
- Conditions
- stage III/IV ovarian, tubal and peritoneal carcinomas
- Registration Number
- JPRN-C000000005
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 56
Inclusion Criteria
Not provided
Exclusion Criteria
-synchronous or metachronous (within 5 years) malignancy other than carcinoma in situ -pregnant or nursing -severe mental disorders -systemic and continuous use of steroidal drugs -active infections -uncontrolled hypertension -diabetes mellitus, uncontrolled or controlled with insulin -history of cardiac failure, unstable angina, myocardial infarction within 6 months prior to the registration -liver cirrhosis or bleeding tendency contraindicating debulking surgery -intestinal occlusion necessary for surgical treatment -hypersensitivity to alcohol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method